• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溴化物、司替戊醇和左乙拉西坦对两名婴儿恶性游走性部分性癫痫发作患者的疗效。

The efficacy of bromides, stiripentol and levetiracetam in two patients with malignant migrating partial seizures in infancy.

机构信息

University of Belfrade, Mothers and Child Health Care Institute, Dr. Vukan Cupic, Belgrade, Serbia.

出版信息

Epileptic Disord. 2011 Mar;13(1):22-6. doi: 10.1684/epd.2011.0402.

DOI:10.1684/epd.2011.0402
PMID:21393091
Abstract

The syndrome of malignant migrating partial seizures in infancy is a devastating, age-specific, epileptic encephalopathy, which still presents an aetiological, pathophysiological and therapeutic problem. In this study, we present two patients who were diagnosed with the disease, based on electroclinical symptoms. The patients were treated with a combination of sodium bromide, stiripentol and levetiracetam. The first patient unequivocally responded, following a course of ineffective conventional drugs, and the second, who was diagnosed and treated immediately, showed a more significant therapeutic response. Antiepileptic drugs, previously reported to be beneficial in case reports, when given concomitantly, may substantially reduce the number and severity of seizures, without influence on psychomotor development. [Published with video sequences].

摘要

婴儿恶性游走性部分性癫痫综合征是一种具有破坏性的、特定于年龄的癫痫性脑病,目前仍然存在病因、病理生理和治疗方面的问题。在这项研究中,我们根据电临床症状,介绍了两名被诊断为该病的患者。这两名患者接受了溴化钠、司替戊醇和左乙拉西坦联合治疗。第一位患者在经历了一系列常规药物治疗无效后,对治疗有明确的反应,第二位患者在被明确诊断和立即治疗后,显示出了更显著的治疗反应。在病例报告中曾有报道称,一些抗癫痫药物联合使用时,可能会显著减少发作的次数和严重程度,而对精神运动发育没有影响。[附有视频序列]。

相似文献

1
The efficacy of bromides, stiripentol and levetiracetam in two patients with malignant migrating partial seizures in infancy.溴化物、司替戊醇和左乙拉西坦对两名婴儿恶性游走性部分性癫痫发作患者的疗效。
Epileptic Disord. 2011 Mar;13(1):22-6. doi: 10.1684/epd.2011.0402.
2
Levetiracetam in a neonate with malignant migrating partial seizures.左乙拉西坦用于一名患有恶性迁移性部分性癫痫的新生儿。
Pediatr Neurol. 2006 Jan;34(1):55-9. doi: 10.1016/j.pediatrneurol.2005.06.011.
3
Malignant migrating partial seizures of infancy controlled by stiripentol and clonazepam.婴儿期恶性迁移性部分性癫痫发作可由司替戊醇和氯硝西泮控制。
Brain Dev. 2013 Feb;35(2):177-80. doi: 10.1016/j.braindev.2012.03.016. Epub 2012 Apr 20.
4
Potassium bromide for treatment of malignant migrating partial seizures in infancy.溴化钾治疗婴儿期恶性游走性部分性癫痫发作。
Pediatr Neurol. 2013 Nov;49(5):355-7. doi: 10.1016/j.pediatrneurol.2013.05.016. Epub 2013 Aug 19.
5
Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.左乙拉西坦辅助治疗婴幼儿难治性局灶性癫痫发作
Epilepsia. 2009 May;50(5):1141-9. doi: 10.1111/j.1528-1167.2008.01981.x. Epub 2009 Feb 21.
6
Levetiracetam-induced seizure aggravation associated with continuous spikes and waves during slow sleep in children with refractory epilepsies.左乙拉西坦致难治性癫痫患儿睡眠中慢波睡眠期持续棘慢波发作加重
Epileptic Disord. 2010 Jun;12(2):146-50. doi: 10.1684/epd.2010.0305. Epub 2010 May 20.
7
Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA).左乙拉西坦的起效时间:一项采用治疗性癫痫发作密集分析(TISA)的随机对照试验。
Epilepsia. 2006 Mar;47(3):516-22. doi: 10.1111/j.1528-1167.2006.00461.x.
8
Levetiracetam: new preparation. For some patients with refractory partial epilepsy.
Prescrire Int. 2003 Apr;12(64):53-4.
9
Efficacy and safety of levetiracetam in the treatment of Panayiotopoulos syndrome.左乙拉西坦治疗潘纳约托普洛斯综合征的疗效与安全性。
Epilepsy Res. 2009 Aug;85(2-3):318-20. doi: 10.1016/j.eplepsyres.2009.03.024. Epub 2009 May 6.
10
Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.左乙拉西坦1000 - 3000毫克/天治疗难治性部分性发作患者的疗效和安全性:一项多中心、开放标签单臂研究。
Epilepsy Res. 2005 Jan;63(1):1-9. doi: 10.1016/j.eplepsyres.2004.09.005. Epub 2005 Jan 6.

引用本文的文献

1
Efficacy of Stiripentol Beyond Dravet Syndrome: A Retrospective Medical Record Review of Patients with Drug-Resistant Epilepsies.司替戊醇在德雷维特综合征之外的疗效:耐药性癫痫患者的回顾性病历审查
Neurol Ther. 2025 Jun;14(3):1129-1150. doi: 10.1007/s40120-025-00755-5. Epub 2025 May 3.
2
Efficacy and tolerability of add-on stiripentol in real-world clinical practice: An observational study in Dravet syndrome and non-Dravet developmental and epileptic encephalopathies.附加型司替戊醇在真实临床实践中的疗效和耐受性:一项 Dravet 综合征和非 Dravet 发育性和癫痫性脑病的观察性研究。
Epilepsia Open. 2024 Feb;9(1):164-175. doi: 10.1002/epi4.12847. Epub 2023 Nov 8.
3
Stiripentol in the Management of Epilepsy.
Stiripentol 在癫痫治疗中的应用。
CNS Drugs. 2017 May;31(5):405-416. doi: 10.1007/s40263-017-0432-1.
4
Migrating partial seizures of infancy: expansion of the electroclinical, radiological and pathological disease spectrum.婴儿部分性发作性癫痫迁移:电临床、放射和病理疾病谱的扩展。
Brain. 2013 May;136(Pt 5):1578-91. doi: 10.1093/brain/awt073. Epub 2013 Apr 18.
5
De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy.新生功能获得性 KCNT1 通道突变导致婴儿局灶性癫痫伴游走性阵挛。
Nat Genet. 2012 Nov;44(11):1255-9. doi: 10.1038/ng.2441. Epub 2012 Oct 21.